ELF5 and neoplasm: Additional events may occur subsequent to this decision that alter ELF5 expression and these may be involved in aspects of tumor progression, such as the acquisition of insensitivity to antiestrogens when ELF5 expression increases in the context of luminal breast cancer, or the acquisition of the mesenchymal phenotype when ELF5 expression is lost in basal breast cancer.